Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
These are the headlines you Need 2 Know.
These are the headlines you Need 2 Know.
Jed McCaleb, the co-founder of the Stellar Development Foundation, told Cheddar how blockchain technology can revolutionize how digital payments are tracked and secured.
These are the headlines you Need 2 Know.
These are the headlines you Need 2 Know.
John Carreyrou, the Wall Street Journal investigative reporter who first exposed the fraud at blood-testing company Theranos, said the former CEO of the once high-flying start-up had a chance to minimize the pain years ago, but instead used what money the company had to hide the truth.
These are the headlines you Need 2 Know.
These are the headlines you Need 2 Know.
In its pick of two small start-ups over Bird, Lime, Uber, and Lyft, San Francisco sent a signal that the most valuable mobility companies' "launch first, ask questions later" approach is catching up to them. Scoot Global and Skip were chosen because they said they would keep riders off the sidewalks and would provide services to low-income residents. Meanwhile, Santa Monica announced that it would open its shared mobility pilot program to e-scooters from Uber, Lyft, Bird, and Lime.
Paul Johnson, partner at Harbor Peak, said regulators are nervous about being interpreted as backing crypto investing. But Bitcoin and Ethereum continue to benefit from widespread user adoption, while other platforms will likely fade away.
